Felwick, R
23  Ergebnisse:
Personensuche X
?
1

P128 Salt-Inducible Kinase 2 is a promising therapeutic tar..:

McMillan, L ; Felwick, R ; Barbeta, G...
Journal of Crohn's and Colitis.  18 (2024)  Supplement_1 - p. i422-i422 , 2024
 
?
2

P384 High incidence of hyperglycaemia in steroid treated ho..:

McDonnell, M ; Harris, R ; Mills, T...
Journal of Crohn's and Colitis.  13 (2019)  Supplement_1 - p. S299-S300 , 2019
 
?
3

P523 New guidance on therapeutic drug monitoring; potential..:

Felwick, R ; Johnson, H ; Dewhurst, H...
Journal of Crohn's and Colitis.  12 (2018)  supplement_1 - p. S370-S371 , 2018
 
?
4

Editorial: CT‐P13, a biosimilar of anti‐tumour necrosis fac..:

Felwick, R. ; Cummings, J. R. F.
Alimentary Pharmacology & Therapeutics.  45 (2017)  10 - p. 1370-1371 , 2017
 
?
5

Thiopurine withdrawal during sustained clinical remission i..:

Kennedy, N. A. ; Kalla, R. ; Warner, B....
Alimentary Pharmacology & Therapeutics.  40 (2014)  11-12 - p. 1313-1323 , 2014
 
?
7

Thiopurine withdrawal during sustained clinical remission i..:

Kennedy, N. A ; Kalla, R ; Warner, B...
Kennedy , N A , Kalla , R , Warner , B , Gambles , C J , Musy , R , Reynolds , S , Dattani , R , Nayee , H , Felwick , R , Harris , R , Marriott , S , Senanayake , S M , Lamb , C A , Al-Hilou , H , Gaya , D R , Irving , P M , Mansfield , J , Parkes , M , Ahmad , T , Cummings , J R F , Arnott , I D , Satsangi , J , Lobo , A J , Smith , M , Lindsay , J O & Lees , C W 2014 , ' Thiopurine withdrawal during sustained clinical remission in inflammatory bowel disease : Relapse and recapture rates, with predictive factors in 237 patients ' , Alimentary Pharmacology and Therapeutics , vol. 40 , no. 11-12 , pp. 1313-1323 . https://doi.org/10.1111/apt.12980.  , 2014
 
?
 
?
 
?
10

Thiopurine withdrawal during sustained clinical remission i..:

Kennedy, N. A ; Kalla, R ; Warner, B...
Kennedy , N A , Kalla , R , Warner , B , Gambles , C J , Musy , R , Reynolds , S , Dattani , R , Nayee , H , Felwick , R , Harris , R , Marriott , S , Senanayake , S M , Lamb , C A , Al-Hilou , H , Gaya , D R , Irving , P M , Mansfield , J , Parkes , M , Ahmad , T , Cummings , J R F , Arnott , I D , Satsangi , J , Lobo , A J , Smith , M , Lindsay , J O & Lees , C W 2014 , ' Thiopurine withdrawal during sustained clinical remission in inflammatory bowel disease : Relapse and recapture rates, with predictive factors in 237 patients ' , Alimentary Pharmacology and Therapeutics , vol. 40 , no. 11-12 , pp. 1313-1323 . https://doi.org/10.1111/apt.12980.  , 2014
 
?
11

Thiopurine withdrawal during sustained clinical remission i..:

Kennedy, N.A ; Kalla, R ; Warner, B...
https://eprints.whiterose.ac.uk/108050/1/Thiopurine%20withdrawal%20during%20sustained%20clinical%20remission%20in%20inflammatory%20bowel%20disease%3A%20relapse%20and%20recapture%20rates,%20with%20predictive%20factors%20in%20237%20patients.pdf.  , 2014
 
?
13

Transitioning from Intravenous to Subcutaneous Vedolizumab ..:

Ventress, Esther ; Young, David ; Rahmany, Sohail...
Journal of Crohn's and Colitis.  16 (2021)  6 - p. 911-921 , 2021
 
1-15